Devonian Health Group Inc. GSD.V
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 128.80K | 351.80K | 758.30K | 930.60K | 5.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 128.80K | 351.80K | 758.30K | 930.60K | 5.18M |
| Cost of Revenue | -14.60K | 327.80K | 376.30K | 3.70K | 3.28M |
| Gross Profit | 143.40K | 24.00K | 382.00K | 926.90K | 1.90M |
| SG&A Expenses | 1.33M | 1.34M | 1.18M | 978.10K | 1.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 23.20K | 23.90K | 23.80K | 23.10K | 22.00K |
| Total Operating Expenses | 1.54M | 1.97M | 1.91M | 1.23M | 5.20M |
| Operating Income | -1.41M | -1.62M | -1.15M | -301.50K | -21.30K |
| Income Before Tax | -1.41M | -1.61M | -1.12M | -282.20K | -3.38M |
| Income Tax Expenses | -- | -- | -- | -9.20K | -- |
| Earnings from Continuing Operations | -1.41M | -1.61M | -1.12M | -272.90K | -3.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.41M | -1.61M | -1.12M | -272.90K | -3.38M |
| EBIT | -1.41M | -1.62M | -1.15M | -301.50K | -21.30K |
| EBITDA | -1.41M | -1.59M | -1.12M | -276.20K | 41.40K |
| EPS Basic | -0.51 | -0.58 | -0.41 | -0.11 | -1.37 |
| Normalized Basic EPS | -0.32 | -0.36 | -0.25 | -0.07 | 0.01 |
| EPS Diluted | -0.51 | -0.58 | -0.41 | -0.11 | -1.37 |
| Normalized Diluted EPS | -0.32 | -0.36 | -0.25 | -0.07 | 0.01 |
| Average Basic Shares Outstanding | 2.77M | 2.77M | 2.76M | 2.47M | 2.47M |
| Average Diluted Shares Outstanding | 2.77M | 2.77M | 2.76M | 2.47M | 2.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |